# 68Ga-P16-093 PET/CT Imaging in the Salivary Gland

> **NCT06049368** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Peking Union Medical College Hospital** · enrollment: 40 (estimated)

## Conditions studied

- Primary Sjögren Syndrome

## Interventions

- **DRUG:** 68Ga-P16-093

## Key facts

- **NCT ID:** NCT06049368
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-10-01
- **Primary completion:** 2023-12-30
- **Final completion:** 2024-03-31
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2023-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06049368

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06049368, "68Ga-P16-093 PET/CT Imaging in the Salivary Gland". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06049368. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
